Share on StockTwits

Sangamo Biosciences (NASDAQ:SGMO) Director Saira Ramasastry unloaded 5,550 shares of Sangamo Biosciences stock on the open market in a transaction dated Monday, June 23rd. The stock was sold at an average price of $15.53, for a total transaction of $86,191.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of Sangamo Biosciences (NASDAQ:SGMO) traded down 1.60% on Wednesday, hitting $15.40. 603,518 shares of the company’s stock traded hands. Sangamo Biosciences has a 52-week low of $7.31 and a 52-week high of $24.69. The stock’s 50-day moving average is $14.13 and its 200-day moving average is $16.39. The company’s market cap is $1.047 billion.

Sangamo Biosciences (NASDAQ:SGMO) last posted its quarterly earnings results on Tuesday, May 6th. The company reported ($0.12) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.13) by $0.01. The company had revenue of $8.10 million for the quarter, compared to the consensus estimate of $6.59 million. During the same quarter in the prior year, the company posted ($0.13) earnings per share. The company’s quarterly revenue was up 76.1% on a year-over-year basis. On average, analysts predict that Sangamo Biosciences will post $-0.29 earnings per share for the current fiscal year.

Sangamo BioSciences, Inc is a clinical stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of zinc finger deoxyribonucleic acid (NASDAQ:SGMO)-binding proteins (ZFPs), a naturally occurring class of proteins.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.